Skip to content
Ceva

Ceva

Pharma·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Ceva?

Ceva is a French Pharma company, currently owned by Societe Generale Capital Partenaires since 2025 and 7 other investors. It changed hands in 2025, when iXO Private Equity sold.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Most recent investor
ARCHIMED
MED Rise · 2024 · Buyout
16 ownership periods · full history below

Key facts

HQFrance
SectorPharma
Key takeaways
  • ·Co-held by Sagard, Grand Sud-Ouest Capital, EMZ Partners, Societe Generale Capital Partenaires, Irdi Capital-Investissement, NiXEN, Merieux Equity Partners and ARCHIMED since 2010.
  • ·Average hold across 6 realized cycles: 8 years.
  • ·12 distinct PE sponsors across ownership cycles.

Ownership history

15 ownership periods · co-invest detected · 1 lender on file

Co-invest · 14 holders · 1 lender · 1999 · present
Irdi Capital-Investissement
1999 · 2014(15yr) · IRDI Capital Croissance · 1996 · Growth
Secondary · to Grand Sud-Ouest Capital

Irdi Capital-Investissement sold Ceva to Grand Sud-Ouest Capital in 2014 after 15 years.

EMZ Partners
EMZ PartnersExited 2014
1999 · 2014(15yr) · EMZ Legacy · 2005
Secondary · to Ceva management with financial investors including Temasek and CDH Investments

EMZ Partners sold Ceva to Ceva management with financial investors including Temasek and CDH Investments in 2014 after 15 years.

PAI Partners
PAI PartnersExited 2003
1999 · 2003(4yr) · PAI LBO Fund · 1998 · Buyout
Secondary · to Industri Kapital

PAI Partners sold Ceva to Industri Kapital in 2003 after 4 years.

IK Partners
IK PartnersExited 2007
2003 · 2007(4yr) · IK 2000 · 2000 · Buyout
MBO · to Management + Euromezzanine + Natexis

IK Partners sold Ceva Santé Animale to Management + Euromezzanine + Natexis in 2007 after 4 years.

NiXEN
NiXENExited 2014
2007 · 2014(7yr) · NiXEN I · 2005 · Buyout
Secondary · to Management and employees with Temasek and CDH Investments

NiXEN sold Ceva to Management and employees with Temasek and CDH Investments in 2014 after 7 years.

Aquiti Gestion
Aquiti GestionExited 2014
2010 · 2014(4yr) · NACI 1 · 2018 · Growth
MBO · to Ceva management and employees with Temasek and CDH Investments

Aquiti Gestion sold Ceva to Ceva management and employees with Temasek and CDH Investments in 2014 after 4 years.

Sagard
SagardActive
2010 · present(16yr) · Sagard · 2002 · Buyout
Grand Sud-Ouest Capital
2014 · present(12yr) · Grand Sud Ouest Capital · 1991 · Buyout
EMZ Partners
2020 · present(6yr) · EMZ 9 · 2020
CIC Private Debt
2022 · present(4yr) · CIC Debt Fund 4 · 2022 · Private Debt
ARCHIMED
ARCHIMEDActive
2025 · present(1yr) · MED Rise · 2024 · Buyout
Merieux Equity Partners
2025 · present(1yr) · Mérieux Participations 4 · 2023 · Buyout
NiXEN
NiXENActive
2025 · present(1yr) · NiXEN II · 2012 · Buyout
Irdi Capital-Investissement
2025 · present(1yr) · IRDI Capital Croissance · 1996 · Growth
Societe Generale Capital Partenaires
2025 · present(1yr) · SGCP Evergreen (balance sheet) · 1991 · Evergreen
iXO Private Equity
exited 2025 · IXO 3 · 2015 · Growth

iXO Private Equity sold Ceva to ARCHIMED and Institut Mérieux in 2025.

Questions

Who owns Ceva?

Ceva is currently owned by Societe Generale Capital Partenaires, Irdi Capital-Investissement and 6 others, through MED Rise, since 2025.

When did Societe Generale Capital Partenaires and 7 others acquire Ceva?

Societe Generale Capital Partenaires and 7 others acquired Ceva in 2025.

Who did Ceva sell to?

iXO Private Equity sold Ceva to ARCHIMED and Institut Mérieux in 2025 (Secondary). Irdi Capital-Investissement sold Ceva to Grand Sud-Ouest Capital in 2014 (Secondary). EMZ Partners sold Ceva to Ceva management with financial investors including Temasek and CDH Investments in 2014 (Secondary).

Who has owned Ceva over time?

Ceva has been through 16 private-equity ownership periods: Irdi Capital-Investissement · via IRDI Capital Croissance · 1999–2014 · sold to Grand Sud-Ouest Capital · (Secondary); PAI Partners · via PAI LBO Fund · 1999–2003 · sold to Industri Kapital · (Secondary); EMZ Partners · via EMZ Legacy · 1999–2014 · sold to Ceva management with financial investors including Temasek and CDH Investments · (Secondary); IK Partners · via IK 2000 · 2003–2007 · sold to Management + Euromezzanine + Natexis · (MBO); NiXEN · via NiXEN I · 2007–2014 · sold to Management and employees with Temasek and CDH Investments · (Secondary); Sagard · via Sagard · since 2010; Aquiti Gestion · via NACI 1 · 2010–2014 · sold to Ceva management and employees with Temasek and CDH Investments · (MBO); Grand Sud-Ouest Capital · via Grand Sud Ouest Capital · 2014–2014; EMZ Partners · via EMZ 9 · 2020–2014; CIC Private Debt · via CIC Debt Fund 4 · 2022–2014; Societe Generale Capital Partenaires · via SGCP Evergreen (balance sheet) · since 2025; Irdi Capital-Investissement · via IRDI Capital Croissance · 2025–2014; NiXEN · via NiXEN II · since 2025; Merieux Equity Partners · via Mérieux Participations 4 · since 2025; ARCHIMED · via MED Rise · since 2025; iXO Private Equity · via IXO 3 · sold to ARCHIMED and Institut Mérieux · (Secondary).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue